Keith W Marshall - Net Worth and Insider Trading

Keith W Marshall Net Worth

The estimated net worth of Keith W Marshall is at least $2 Million dollars as of 2024-05-20. Keith W Marshall is the CFO of Prometheus Biosciences Inc and owns about 9,811 shares of Prometheus Biosciences Inc (RXDX) stock worth over $2 Million. Details can be seen in Keith W Marshall's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Keith W Marshall has not made any transactions after 2023-04-05 and currently still holds the listed stock(s).

Transaction Summary of Keith W Marshall

To

Keith W Marshall Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Keith W Marshall owns 2 companies in total, including Histogen Inc (HSTO) , and Prometheus Biosciences Inc (RXDX) .

Click here to see the complete history of Keith W Marshall’s form 4 insider trades.

Insider Ownership Summary of Keith W Marshall

Ticker Comapny Transaction Date Type of Owner
HSTO Histogen Inc 2020-05-22 EVP & COO & CFO
RXDX Prometheus Biosciences Inc 2023-04-05 Chief Financial Officer

Keith W Marshall Latest Holdings Summary

Keith W Marshall currently owns a total of 1 stock. Keith W Marshall owns 9,811 shares of Prometheus Biosciences Inc (RXDX) as of April 5, 2023, with a value of $2 Million.

Latest Holdings of Keith W Marshall

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RXDX Prometheus Biosciences Inc 2023-04-05 9,811 199.92 1,961,415

Holding Weightings of Keith W Marshall


Keith W Marshall Form 4 Trading Tracker

According to the SEC Form 4 filings, Keith W Marshall has made a total of 4 transactions in Prometheus Biosciences Inc (RXDX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Prometheus Biosciences Inc is the sale of 10,000 shares on April 5, 2023, which brought Keith W Marshall around $1 Million.

Insider Trading History of Keith W Marshall

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Keith W Marshall Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Keith W Marshall Ownership Network

Ownership Network List of Keith W Marshall

No Data

Ownership Network Relation of Keith W Marshall


Keith W Marshall Owned Company Details

What does Histogen Inc do?

Who are the key executives at Histogen Inc?

Keith W Marshall is the EVP & COO & CFO of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .

Histogen Inc (HSTO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Histogen Inc Insider Transactions

No Available Data

Keith W Marshall Mailing Address

Above is the net worth, insider trading, and ownership report for Keith W Marshall. You might contact Keith W Marshall via mailing address: C/o Conatus Pharmaceuticals Inc., 16745 West Bernardo Drive, Suite 200, San Diego Ca 92127.

Discussions on Keith W Marshall

No discussions yet.